Avir Pharma
Pre-clinicalLeveraging our expertise and unique market position to provide enhanced treatment choices for Canadians through novel, specialized medicines.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $15M
About
Leveraging our expertise and unique market position to provide enhanced treatment choices for Canadians through novel, specialized medicines.
Infectious Disease
Funding History
2Total raised:$15M
Series A$12MApr 15, 2022
Seed$3MSep 15, 2020